Free shipping on all orders over $ 500

PND-1186

Cat. No. M4978

All AbMole products are for research use only, cannot be used for human consumption.

PND-1186 Structure
Synonym:

VS-4718

Size Price Availability Quantity
10mM*1mL in DMSO USD 65 In stock
5mg USD 60 In stock
10mg USD 90 In stock
25mg USD 180 In stock
50mg USD 265 In stock
100mg USD 380 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In mice bearing 4T1 tumors, PND-1186 (100 mg/kg s.c.) inhibits 4T1 subcutaneous tumor growth by induction of apoptosis. In mice bearing ID8 tumors, PND-1186 (0.5 mg/mL for p.o.) also causes ovarian carcinoma tumor growth inhibition.Addition of PND-1186 to the drinking water of mice was well tolerated and inhibited ascites- and peritoneal membrane-associated ovarian carcinoma tumor growth associated with the inhibition of FAK Tyr-397 phosphorylation.

Customer Product Validations & Biological Datas
Source Cell Death Differ (2017). Figure 8. PND-1186
Method cell proliferation assay
Cell Lines HCC cells
Concentrations 1 μM
Incubation Time 48 h
Results As expected, 1 μM PND-1186 significantly downregulated EZH2 mRNA and upregulated NOTCH2 expression
Chemical Information
Molecular Weight 501.5
Formula C25H26F3N5O3
CAS Number 1061353-68-1
Solubility (25°C) DMSO 24 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Tanjoni I,et.al. Cancer Biol Ther PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments.

Related FAK Products
NVP-TAE226

Nvp-tae 226 (TAE226) is a potent atP-competitive dual FAK and IGF-1R inhibitor with IC50 of 5.5 nM and 140 nM, respectively. Nvp-tae 226 (TAE226) also effectively inhibited Pyk2, insulin receptor (InsR), with IC50 of 3.5 nM and 40 nM.

PF-562271

PF-562271 is a potent, ATP-competitive, reversible inhibitor of FAK and Pyk2 with IC50 of 1.5 nM and 14 nM, respectively.

PF-573228

PF-573228 is an ATP-competitive inhibitor of FAK with IC50 of 4 nM, ~50- to 250-fold selective for FAK than Pyk2, CDK1/7 and GSK-3β.

PF-00562271

PF-00562271 is the benzenesulfonate salt of PF-562271, which is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.

Defactinib

Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor, with potential antiangiogenic and antineoplastic activities.

  Catalog
Abmole Inhibitor Catalog




Keywords: PND-1186, VS-4718 supplier, FAK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.